189 related articles for article (PubMed ID: 27500301)
21. Risk of pregnancy-related venous thromboembolism and obstetrical complications in women with inherited type I antithrombin deficiency: a retrospective, single-centre, cohort study.
Abbattista M; Gianniello F; Novembrino C; Clerici M; Artoni A; Bucciarelli P; Capecchi M; Peyvandi F; Martinelli I
Lancet Haematol; 2020 Apr; 7(4):e320-e328. PubMed ID: 32112716
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of the use of low-molecular-weight heparin for venous thromboembolism prophylaxis in medical patients.
Du Plessis JA; Van Blydenstein SA; Wong M
S Afr Med J; 2020 Feb; 110(3):235-242. PubMed ID: 32657702
[TBL] [Abstract][Full Text] [Related]
23. Assessment and management of venous thrombo-embolism risk during pregnancy and the puerperium (SAVE): The South African cohort.
Naidoo P; Mothilal R; Snyman LC
S Afr Med J; 2019 Feb; 109(3):186-192. PubMed ID: 30834877
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of obstetric thromboprophylaxis and long-term risk of recurrence of venous thromboembolism.
Lindqvist PG; Bremme K; Hellgren M;
Acta Obstet Gynecol Scand; 2011 Jun; 90(6):648-53. PubMed ID: 21314819
[TBL] [Abstract][Full Text] [Related]
25. Venous thromboembolism during pregnancy or postpartum: findings from the RIETE Registry.
Blanco-Molina A; Trujillo-Santos J; Criado J; Lopez L; Lecumberri R; Gutierrez R; Monreal M;
Thromb Haemost; 2007 Feb; 97(2):186-90. PubMed ID: 17264945
[TBL] [Abstract][Full Text] [Related]
26. Venous thromboembolism prophylaxis in medical ICU patients in Asia (VOICE Asia): a multicenter, observational, cross-sectional study.
Parikh KC; Oh D; Sittipunt C; Kalim H; Ullah S; Aggarwal SK;
Thromb Res; 2012 Apr; 129(4):e152-8. PubMed ID: 22326367
[TBL] [Abstract][Full Text] [Related]
27. Cost-effectiveness of prophylactic low molecular weight heparin in pregnant women with a prior history of venous thromboembolism.
Johnston JA; Brill-Edwards P; Ginsberg JS; Pauker SG; Eckman MH
Am J Med; 2005 May; 118(5):503-14. PubMed ID: 15866253
[TBL] [Abstract][Full Text] [Related]
28. The Safety of Low-Molecular-Weight Heparin During and After Pregnancy.
Lu E; Shatzel JJ; Salati J; DeLoughery TG
Obstet Gynecol Surv; 2017 Dec; 72(12):721-729. PubMed ID: 29280473
[TBL] [Abstract][Full Text] [Related]
29. Use of the Delphi method to facilitate antithrombotics prescription during pregnancy.
Chauleur C; Gris JC; Laporte S; Rancon F; Varlet MN; Decousus H; Mismetti P;
Thromb Res; 2010 Aug; 126(2):88-92. PubMed ID: 20153880
[TBL] [Abstract][Full Text] [Related]
30. Decision Analysis in SHared decision making for Thromboprophylaxis during Pregnancy (DASH-TOP): a sequential explanatory mixed methods pilot study protocol.
Humphries B; León-García M; Bates S; Guyatt G; Eckman M; D'Souza R; Shehata N; Jack S; Alonso-Coello P; Xie F
BMJ Open; 2021 Mar; 11(3):e046021. PubMed ID: 33753445
[TBL] [Abstract][Full Text] [Related]
31. Low-molecular-weight heparins for the prevention and treatment of venous thromboembolism in at-risk pregnant women: a review.
Duhl AJ
J Reprod Med; 2008 Sep; 53(9):657-66. PubMed ID: 18839817
[TBL] [Abstract][Full Text] [Related]
32. A local risk score model for venous thromboembolism prophylaxis for caesarean section in Chinese women and comparison with international guidelines.
Lok WY; Kong CW; To WWK
Taiwan J Obstet Gynecol; 2019 Jul; 58(4):520-525. PubMed ID: 31307744
[TBL] [Abstract][Full Text] [Related]
33. Factors limiting women's adherence to venous thromboembolism prophylaxis after cesarean section in the Gaza Strip: A cross-sectional study.
Aldabbour B; Abu Sidgh O; Haboush I; Jalhum E; Alsmary S; Irheem S; Elamassie S; Zimmo M; Asad MD
Phlebology; 2024 Feb; 39(1):29-36. PubMed ID: 37846865
[TBL] [Abstract][Full Text] [Related]
34. Thromboprophylaxis after cesarean section: decision analysis.
Blondon M
Thromb Res; 2011 Feb; 127 Suppl 3():S9-S12. PubMed ID: 21262452
[TBL] [Abstract][Full Text] [Related]
35. Compliance with the 2009 Royal College of Obstetricians and Gynaecologists guidelines for venous thromboembolic disease prophylaxis in pregnancy and postpartum period in Uruguay.
Grille S; Vitureira G; Morán R; Retamosa L; Alonso V; Gómez LM; Quartara F; Feldman F; López V; Turcatti P; Castro V; Sosa L; Guillermo C; Díaz L; Stevenazzi M
Blood Coagul Fibrinolysis; 2018 Apr; 29(3):252-256. PubMed ID: 29369082
[TBL] [Abstract][Full Text] [Related]
36. Impact of thromboprophylaxis across the US acute care setting.
Huang W; Anderson FA; Rushton-Smith SK; Cohen AT
PLoS One; 2015; 10(3):e0121429. PubMed ID: 25816146
[TBL] [Abstract][Full Text] [Related]
37. Thromboprophylaxis with low-molecular-weight heparin after cesarean delivery.
Blondon M; Perrier A; Nendaz M; Righini M; Boehlen F; Boulvain M; De Moerloose P
Thromb Haemost; 2010 Jan; 103(1):129-37. PubMed ID: 20062923
[TBL] [Abstract][Full Text] [Related]
38. A retrospective study on the use of low-molecular-weight heparin for prevention of pregnancy-related recurrent venous thromboembolism and obstetrical complications.
Abbattista M; Capecchi M; Gianniello F; Artoni A; Bucciarelli P; Ciavarella A; Peyvandi F; Martinelli I
Blood Coagul Fibrinolysis; 2023 Mar; 34(2):111-117. PubMed ID: 36598379
[TBL] [Abstract][Full Text] [Related]
39. Implementation of thromboprophylaxis guidelines.
Cregan A; Higgins JR; O'Shea S
Ir Med J; 2013 Mar; 106(3):80-2. PubMed ID: 23951977
[TBL] [Abstract][Full Text] [Related]
40. American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy.
Bates SM; Rajasekhar A; Middeldorp S; McLintock C; Rodger MA; James AH; Vazquez SR; Greer IA; Riva JJ; Bhatt M; Schwab N; Barrett D; LaHaye A; Rochwerg B
Blood Adv; 2018 Nov; 2(22):3317-3359. PubMed ID: 30482767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
